← back to search

Ainara Mira‐Iglesias

Instituto de Salud Carlos III · ES
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Respiratory viral infections research, Influenza Virus Research Studies, Pneumonia and Respiratory Infections, and COVID-19 Clinical Research Studies.
h-index
18
citations
3,923
works
64
NIH funding
primary concept
Medicine
email

Recent publications

Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform
EClinicalMedicine 2024cited by 18position: middledoi
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
The Lancet 2022cited by 1,795position: middledoi
Predictors of influenza severity among hospitalized adults with laboratory confirmed influenza: Analysis of nine influenza seasons from the Valencia region, Spain
Influenza and Other Respiratory Viruses 2022cited by 23position: middledoi
Global burden of acute lower respiratory infection associated with human parainfluenza virus in children younger than 5 years for 2018: a systematic review and meta-analysis
The Lancet Global Health 2021cited by 97position: middledoi
Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines
Zenodo (CERN European Organization for Nuclear Research) 2021cited by 25position: middledoi
Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study
The Lancet Global Health 2020cited by 482position: middledoi
Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study
The Lancet Global Health 2020cited by 218position: middledoi
Complicated hospitalization due to influenza: results from the Global Hospital Influenza Network for the 2017–2018 season
BMC Infectious Diseases 2020cited by 58position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2024–2024)Srinivas Rao Valluri · Pfizer (United States)1 papers (2024–2024)Kaatje Bollaerts · KU Leuven1 papers (2024–2024)Alejandro Orrico‐Sánchez · Instituto de Salud Carlos III1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024)Leonie de Munter · KU Leuven1 papers (2024–2024)Mustapha M. Mustapha · Shanghai Medical College of Fudan University1 papers (2024–2024) · 1 papers (2024–2024)Marianna Mitratza · KU Leuven1 papers (2024–2024)Jennifer L. Nguyen · Columbia University1 papers (2024–2024)Nieves Derqui · NIHR Imperial Biomedical Research Centre1 papers (2022–2022)Charlotte Martin · Vrije Universiteit Brussel1 papers (2024–2024)Laura Drikite · KU Leuven1 papers (2024–2024)Andrés Antón · Hebron University1 papers (2024–2024)Luis Jódar · Pfizer (United States)1 papers (2024–2024)Jingyan Yang · Pfizer (United States)1 papers (2024–2024)Gerrit L. ten Kate · Imperial College Healthcare NHS Trust1 papers (2024–2024)Eduardo Conde‐Sousa · KU Leuven1 papers (2024–2024)Javier Díez‐Domingo · Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana1 papers (2022–2022)